| Product NDC: | 0591-3159 | 
| Proprietary Name: | Ursodiol | 
| Non Proprietary Name: | Ursodiol | 
| Active Ingredient(s): | 300 mg/1 & nbsp; Ursodiol | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | CAPSULE | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0591-3159 | 
| Labeler Name: | Watson Laboratories, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA019594 | 
| Marketing Category: | NDA AUTHORIZED GENERIC | 
| Start Marketing Date: | 19871231 | 
| Package NDC: | 0591-3159-01 | 
| Package Description: | 100 CAPSULE in 1 BOTTLE (0591-3159-01) | 
| NDC Code | 0591-3159-01 | 
| Proprietary Name | Ursodiol | 
| Package Description | 100 CAPSULE in 1 BOTTLE (0591-3159-01) | 
| Product NDC | 0591-3159 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Ursodiol | 
| Dosage Form Name | CAPSULE | 
| Route Name | ORAL | 
| Start Marketing Date | 19871231 | 
| Marketing Category Name | NDA AUTHORIZED GENERIC | 
| Labeler Name | Watson Laboratories, Inc. | 
| Substance Name | URSODIOL | 
| Strength Number | 300 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Bile Acid [EPC],Bile Acids and Salts [Chemical/Ingredient] |